NCT05410340

EEG and NIRS in Preterm Infants

Name: Clinical Trial NCT05410340
Creator: University of Salamanca
Keywords: Premature Birth, Vojta Therapy, other, clinical trial

Brain Activation and Oxygenation Through Reflex Locomotion Therapy (Vojta) and Massage in Preterm Infants

University of Salamanca·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Premature Birth
Drug/Device/Intervention: Vojta Therapy
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: University of Salamanca

Timeline & enrollment

Phase: N/A
Start date: Oct 03, 2022
End date: Dec 31, 2023
Enrollment: 80 participants

Primary outcome

EEG (Alpha, Beta, Theta),NIRS

Summary

Experimental cross-sectional study of a single application (vojta therapy or massage) in preterm and non-preterm infants to test whether there are differences in brain activation and oxygenation that occur with both techniques between term and preterm infants.  Secondly, the brain activation and oxygenation produced by both physiotherapy techniques will be tested separately to establish comparisons between the two groups.  Finally, between 3 - 6 months, we will analyse whether there are changes in gaze fixation (eye tracker) in the 4 study arms to see if there are differences between term and preterm infants but also the differences between the immediate effectiveness of both techniques.

ICD-10 classifications

Fetus and newborn affected by precipitate deliveryPreterm delivery without spontaneous labourDisorders related to short gestation and low birth weight, not elsewhere classifiedOther preterm infantsPreterm spontaneous labour with preterm delivery

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05410340
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05410340 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Salamanca and is currently Not yet recruiting. The study focuses on Premature Birth. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.